共 50 条
Next Generation Sequencing in Non-Small Cell Lung Cancer: Pitfalls and Opportunities
被引:19
|作者:
Lazzari, Chiara
[1
]
Bulotta, Alessandra
[1
]
Cangi, Maria Giulia
[2
]
Bucci, Gabriele
[3
]
Pecciarini, Lorenza
[2
]
Bonfiglio, Silvia
[3
]
Lorusso, Vincenza
[1
,2
]
Ippati, Stefania
[1
]
Arrigoni, Gianluigi
[2
]
Grassini, Greta
[2
]
Doglioni, Claudio
[2
]
Gregorc, Vanesa
[1
]
机构:
[1] IRCCS San Raffaele, Dept Oncol, I-20132 Milan, Italy
[2] IRCCS San Raffaele, Dept Pathol, I-20132 Milan, Italy
[3] IRCCS San Raffaele, Ctr Omics Sci, I-20132 Milan, Italy
来源:
关键词:
non-small cell lung cancer;
next-generation sequencing;
molecular tumor board;
BIOLOGY;
DRUGS;
D O I:
10.3390/diagnostics10121092
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Lung cancer remains the first cause of cancer-related deaths worldwide. Thanks to the improvement in the knowledge of the biology of non-small cell lung cancer (NSCLC), patients' survival has significantly improved. A growing number of targetable molecular alterations have been identified. Next-generation sequencing (NGS) has become one of the methodologies entered in clinical practice and was recently recommended by the European society for medical oncology (ESMO) to perform a comprehensive molecular characterization in patients with cancer. The current review provides an overview of the clinical trials that have explored the impact of NGS in patients with cancer, its limits, and advantages.
引用
收藏
页数:12
相关论文